GMAC Expands Global Representation in Board and School Membership
New board chair, board members and member school span footprint from Asia to America RESTON, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) — The Graduate Management Admission Council (GMAC), a global association of More...
Le GMAC étend sa représentation mondiale au sein de son conseil d’administration et accueille une nouvelle école
Un nouveau président du conseil d’administration, de nouveaux membres au conseil et une nouvelle école membre, pour une présence de l’Asie à l’Amérique RESTON, Virginie, 05 sept. 2023 (GLOBE More...
eLichens is introducing the first Natural Gas Detector integrating NB-IoT/LTE-M Connectivity from Sequans
Avolta Natural Gas Detector with NB-IoT/LTE-M Connectivity eLichens is introducing the first Natural Gas Detector integrating NB-IoT/LTE-M Connectivity GRENOBLE, France, Sept. 05, 2023 (GLOBE NEWSWIRE) — More...
Zenas BioPharma ประกาศข้อตกลงว่าด้วยใบอนุญาตเชิงกลยุทธ์และความร่วมมือกับ Bristol Myers Squibb เพื่อพัฒนาและจำหน่าย Novel Bi-Functional Antibody Obexelimab ในญี่ปุ่น เกาหลีใต้ ไต้หวัน สิงคโปร์ ฮ่องกง และออสเตรเลีย
ความร่วมมือดังกล่าวช่วยส่งเสริมวิสัยทัศน์ของ Zenas ที่จะนำยาภูมิคุ้มกันวิทยาที่ใช้นวัตกรรมที่ทันสมัยไปสู่ผู้ป่วยทั่วโลก More...
Zenas BioPharma Fecha Acordo de Licenciamento e Colaboração Estratégica com a Bristol Myers Squibb para Desenvolvimento e Comercialização do Novo Anticorpo Bifuncional Obexelimab no Japão, Coreia do Sul, Taiwan, Cingapura, Hong Kong e Austrália
Colaboração promove a visão da Zenas de oferecer medicamentos inovadores baseados em imunologia para pacientes em todo o mundo, aproveitando a experiência de longa data da Bristol Myers Squibb com doenças imunomediadas A More...
Zenas BioPharma annonce un accord de licence et de collaboration stratégique avec Bristol Myers Squibb dans le but de développer et commercialiser le nouvel anticorps bifonctionnel obéxélimab au Japon, en Corée du Sud, à Taïwan, à Singapour, à Hong Kong et en Australie
Cette collaboration renforce la vision de Zenas consistant à apporter des médicaments innovants basés sur l’immunologie aux patients dans le monde entier en s’appuyant sur l’expertise de longue More...
Zoom introduces Zoom AI Companion — available at no additional cost with paid Zoom user accounts
New generative AI-powered assistant helps improve collaboration and productivity SAN JOSE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — Today, Zoom Video Communications, Inc. (NASDAQ: ZM) announced that Zoom More...
Gorilla Technology Commences Smart Government Project in Egypt, Marking A New Era in AI Innovation
LONDON, Sept. 05, 2023 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and cybersecurity, with More...
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia
Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated diseases Zenas More...
ApeX Pro’s New Smart Liquidity Pools Bring the Best of DeFi to Bybit
DUBAI, UNITED ARAB EMIRATES – Media OutReach – 5 September 2023 – Bybit, the world’s third most visited crypto exchange, is again collaborating with permissionless and decentralized trading platform More...